In individuals with MASLD, potential mechanisms may include insulin resistance resulting from hepatic fat infiltration [62], physical inactivity, and muscle disuse, all of which contribute to decreased muscle function [4]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.